Mechanism of ECM regulation of actin nucleation during morphogenesis.

形态发生过程中 ECM 调节肌动蛋白成核的机制。

• 批准号: 7893597
• 负责人: Martha C Soto
• 金额: $ 29.34万
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-15 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7893597
• 关键词: Actins; Address; Affect; Animal Model; Animals; Antibodies; Architecture; Axon; Caenorhabditis elegans; Cancer Detection; Cancerous; Cell Polarity; Cell membrane; Cells; Cicatrix; Cloning; Colorectal Cancer; Complex; Cues; Cytoskeleton; Defect; Development; ECM receptor; Embryo; Enhancers; Ensure; Epithelial; Extracellular Matrix; F-Actin; Failure; Genes; Genetic; Genetic Screening; Goals; Growth; Guanosine Triphosphate Phosphohydrolases; Homologous Gene; Human; Human Development; Knock-out; Knowledge; Lead; Learning; Malignant - descriptor; Malignant Neoplasms; Malignant neoplasm of lung; Melanoma Cell; Modeling; Molecular; Morphogenesis; Movement; Mus; Mutation; Neoplasm Metastasis; Neuroblastoma; Neurons; Phenotype; Process; Proteins; Public Health; Receptor Signaling; Recruitment Activity; Regulation; Research; Research Design; Role; Signal Pathway; Signal Transduction; Testing; Tissues; anticancer research; axonal guidance; blastomere structure; cancer cell; cell motility; clinically relevant; extracellular; human disease; insight; metastatic colorectal; migration; mouse model; mutant; neuroblast; polarized cell; prevent; public health relevance; receptor; research study

DESCRIPTION (provided by applicant): The growth and spread of cancerous cells requires alterations in cell polarity, and in the organization of the actin cytoskeleton. While our studies have identified complexes that control the actin cytoskeleton, we now need to determine how these actin nucleation complexes are polarized during development. We are identifying extracellular cues and components of signaling pathways that regulate the ability of these complexes to organize cytoskeletal polarity and initiate migrations. Using knockout mutants in a model organism, C. elegans, we have shown that loss of the GTPase CED-10/Rac1, any component of the actin nucleating Arp2/3 complex, or of its activator, the WAVE/SCAR complex, results in the same phenotype: failure in embryonic cell migrations, morphogenesis and altered epithelial polarity. We refer to the actin nucleation cassette encoded by Rac1- WAVE/SCAR-Arp2/3 as the GEX (GTPase/Enhancer of nucleation/actin nucleation eXecution) complex. Mammalian homologs of GEX molecules are misregulated in cancers. For example, WAVE2 is misexpressed in malignant human lung cancers and metastatic colorectal cancers (Semba et al. 2006; Iwaya et al. 2007). However, how these actin nucleation proteins are misregulated during metastasis is not understood. We have determined that some extracellular matrix (ECM) axonal guidance molecules, in addition to their role in axons, affect embryonic migrations, and they regulate the levels of GEX proteins. Objective/Hypothesis: We hypothesize that ECM signals regulate cytoskeletal polarity by recruiting, stabilizing, and/or activating GEX actin nucleation complexes in specific regions of cells. We propose to identify the guidance cues and to analyze how these upstream signals activate the GEX components to initiate migrations. Specific Aims: (1) To determine whether extracellular matrix receptors regulate actin nucleation. (2)To determine which tissues are sending and receiving the signals that lead to cell migrations in the embryo. (3) To use targeted genetics to identify new regulators of the GEX complex. Study design: In Aim 1 we determine the role of ECM receptors in polarized F-actin enrichment, and test if ECM receptors require the GEX complex to affect actin enrichment during morphogenesis. In Aim 2 we determine the architecture of tissue signaling by testing which tissues require the activity of GEX and ECM components during morphogenetic movements. In Aim 3 we identify new regulators of embryonic cell migrations by molecularly cloning new gex mutants. Clinical relevance: The ability of cancer cells to migrate is strongly correlated with malignant progression and metastasis. The human homolog of one of the genes we have identified in C. elegans, WAVE3, is down regulated in neuroblastomas and a mutation in WAVE3 has been connected to neuroblastoma and to changes in the actin cytoskeleton. Our studies may identify genetic targets for cancer detection and provide mechanistic insight into metastasis. PUBLIC HEALTH RELEVANCE: These studies on the regulation of cell migrations address a major question in development and in cancer research: how cell migrations are initiated and controlled for healthy growth. During human development we need to identify the molecules that ensure healthy growth. To treat cancers before they spread, we need to understand how the process of metastasis is regulated.

描述（由申请人提供）：癌细胞的生长和扩散需要改变细胞极性和肌动蛋白细胞骨架的组织。虽然我们的研究已经确定了控制肌动蛋白细胞骨架的复合物，但我们现在需要确定这些肌动蛋白成核复合物在发育过程中是如何极化的。我们正在识别细胞外线索和信号通路的组成部分，这些信号通路调节这些复合物组织细胞骨架极性和启动迁移的能力。通过在模型生物秀丽隐杆线虫中使用敲除突变体，我们发现GTPase CED-10/Rac1（肌动蛋白成核Arp2/3复合体的任何组分）或其激活剂WAVE/SCAR复合体的缺失都会导致相同的表型：胚胎细胞迁移、形态发生和上皮极性改变的失败。我们将Rac1- WAVE/SCAR-Arp2/3编码的肌动蛋白成核盒称为GEX （GTPase/增强子成核/肌动蛋白成核执行）复合物。GEX分子的哺乳动物同源物在癌症中被错误调控。例如，WAVE2在恶性人类肺癌和转移性结直肠癌中错误表达（Semba et al. 2006; Iwaya et al. 2007）。然而，这些肌动蛋白成核蛋白在转移过程中是如何被错误调控的尚不清楚。我们已经确定了一些细胞外基质（ECM）轴突引导分子，除了它们在轴突中的作用外，还影响胚胎迁移，并调节GEX蛋白的水平。目的/假设：我们假设ECM信号通过募集、稳定和/或激活细胞特定区域的GEX肌动蛋白成核复合物来调节细胞骨架极性。我们建议识别引导线索，并分析这些上游信号如何激活GEX成分来启动迁移。具体目的：(1)确定细胞外基质受体是否调控肌动蛋白成核。(2)确定胚胎中哪些组织在发送和接收导致细胞迁移的信号。(3)利用靶向遗传学鉴定GEX复合物的新调控因子。研究设计：在目的1中，我们确定了ECM受体在极化f -肌动蛋白富集中的作用，并测试了ECM受体在形态发生过程中是否需要GEX复合物来影响肌动蛋白富集。在目标2中，我们通过测试哪些组织在形态发生运动中需要GEX和ECM组分的活性来确定组织信号的结构。在Aim 3中，我们通过分子克隆新的基因突变体来鉴定胚胎细胞迁移的新调控因子。临床意义：癌细胞的迁移能力与恶性进展和转移密切相关。我们在秀丽隐杆线虫中发现的其中一个基因WAVE3的人类同源基因在神经母细胞瘤中被下调，并且WAVE3的突变与神经母细胞瘤和肌动蛋白细胞骨架的变化有关。我们的研究可以确定癌症检测的基因靶点，并提供转移的机制。公共卫生相关性：这些关于细胞迁移调控的研究解决了发育和癌症研究中的一个主要问题：如何启动和控制细胞迁移以促进健康生长。在人类发育过程中，我们需要确定确保健康生长的分子。为了在癌症扩散之前进行治疗，我们需要了解转移过程是如何被调节的。